Women not taking statins with higher LDL cholesterol levels — above 110 mg/dL — were 2-12% less likely to get Parkinson’s disease than those with lower cholesterol levels.
Women not taking statins with the middle one-third LDL cholesterol levels — above 110 mg/dL — were 2% less likely to get Parkinson’s during an average follow-up of 7.9 years compared to women with the one-third lowest total cholesterol levels.
Women not taking statins with the highest one-third LDL cholesterol levels — above 140 mg/dL — were 12% less likely to get Parkinson’s compared to women with the one-third lowest total cholesterol levels.
(I have requested a copy of the paper to get exact LDL cholesterol levels for each group. I will update this article when I do.)
© Copyright 2003-2017 - Larry Hobbs - All Rights Reserved.